Beaconcure

Israel - Tel Aviv

• 15/06/2023
• Series B
• $14,000,000

With Beaconcure, pharmaceutical companies and CROs can validate clinical trial data for regulatory approval while cutting submission timelines in half!

By using 'Verify' by Beaconcure, any data inconsistency will be detected automatically during the QC process, reducing handling time and eliminating the possibility of an error-filled submission.
In collaboration with Pfizer, Beaconcure algorithms are designed and trained to support all types of therapeutic areas and study sizes.
With our technology, customers can introduce new treatments earlier to patients, while maintaining IP protection deadlines, accelerating the pipeline so that they can make early revenue and be first to market.
#automation
#machineLearning
#AI
#statisticalanalysis
#regulatorysubmission
#clinicaltrial

Related People

Yoran BarFounder

United States - Boston, Massachusetts

I consider myself a mission-oriented entrepreneur with a solid track record developing & deploying B2B Enterprise data-centric systems. In the last 20 years, I performed senior business executive roles in the Israeli High Technology industry as well as in Europe and the US.
Currently serving as CEO and Co-founder of Beaconcure Inc. and Beaconcure Ltd. a growing startup offering a SaaS solution for clinical data validation. The product serves multinational Pharma and CRO customers world wide.
I also served as the founding Director of 'The HAC', a successful Urban Accelerator based in Israel, where I perform advisory duties supporting the organization and its young entrepreneurs as a pro bono project.
I also operate as Advisory Member for Science Abroad- the organization for Israeli scientists abroad.
I completed my MBA from the University of Den Haag and a BA in Psychology & Communications from the University of South Africa.

LinkedIn https://www.linkedin.com/in/yoranbar/